WELNECTA

Live / Registered — Registered (as of 17 Feb 2026)

What this means for you

Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79425336
Registration number
8140113
Mark type
Stylized text
Filed
10 Apr 2025
Published for opposition
30 Dec 2025
Registered
17 Feb 2026
Attorney of record
Christina M. Licursi

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceuticals for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products and preparations for use in the treatment and prevention of disease in the field of oncology; pharmaceutical products and preparations for use in the treatment of cancer

Owner

Prosecution history

  • 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
  • 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 30 Dec 2025 — PUBLISHED FOR OPPOSITION
  • 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 04 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 18 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 18 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 18 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 15 Nov 2025 — REFUSAL PROCESSED BY IB
  • 29 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
  • 29 Oct 2025 — REFUSAL PROCESSED BY MPU
  • 12 Sept 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
  • 11 Sept 2025 — NON-FINAL ACTION WRITTEN
  • 05 Sept 2025 — ASSIGNED TO EXAMINER

View this trademark record on Marksy